Annual Report

Overview

The report describes Sun Pharma's specialty-led growth strategy and global operating scale, while FY18 consolidated revenue from operations was INR 264,894.6 million. It also reports voluntary CSR spending, including health, education, water, and environmental initiatives, and describes energy-efficiency measures such as motion sensors, LED lighting, boiler improvements, and biomass fuel use.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2017
Period: Ends 31 March 2018
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services